Skip to main content
B

BioShin

Inactive

BioShin is a clinical stage biopharmaceutical company focused on developing targeted therapies for rare diseases through advanced drug delivery systems. Their approach aims to improve patient outcomes by enhancing the efficacy and safety profiles of existing treatments.

Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Features

  • BioShin is a clinical stage biopharmaceutical company focused on developing targeted therapies for rare diseases through advanced drug delivery systems. Their approach aims to improve patient outcomes by enhancing the efficacy and safety profiles of existing treatments.
This profile is AI-generated and may contain inaccuracies.